Multiple randomized clinical trials and observational studies have shown that an omega-3 supplementation significantly reduces inflammatory biomarkers such as C-reactive protein (CRP), IL-6, and TNF-α in patients with CKD and heart failure [86,87,88]. Here, IL6 is linked to heart failure.